# Effect of Terazosin on ATP Levels in People With Amyotrophic Lateral Sclerosis

> **NCT07224269** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **University of Iowa** · enrollment: 20 (estimated)

## Conditions studied

- Amyotrophic Lateral Sclerosis
- Adenosine Triphosphate Activities

## Interventions

- **DRUG:** Terazosine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07224269
- **Lead sponsor:** University of Iowa
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2027-05-01
- **Final completion:** 2027-05-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07224269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07224269, "Effect of Terazosin on ATP Levels in People With Amyotrophic Lateral Sclerosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07224269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*